Advertisement

Lung

, Volume 197, Issue 1, pp 95–99 | Cite as

Helicobacter pylori Infection Does Not Impact on Lung Transplant Outcome

  • David BennettEmail author
  • Antonella Fossi
  • Giuseppina Chiarello
  • Rosa Metella Refini
  • Luca Luzzi
  • Piero Paladini
  • Maria Materozzi
  • Natale Figura
  • Ranuccio Nuti
  • Paola Rottoli
Lung Transplantation
  • 37 Downloads

Abstract

Background

Helicobacter pylori (HP) is a spiral, gram-negative, microaerophilic bacterium that colonises the human gastric mucosa and is associated with gastrointestinal and extragastrointestinal disorders. Since no data are yet available on HP infection in lung transplant patients, we evaluated the prevalence and impact of HP infection in a population of such patients.

Methods

Sixty-seven lung transplant patients were enrolled in the study (35 females and 32 males, age 48.4 ± 13.3 years), 54 underwent bilateral and 13 single lung transplant. Serum antibodies against HP and CagA were assayed in all subjects.

Results

The prevalence of HP infection in lung transplant patients was similar to that in the general population (49.25% vs. 51.4%), whereas HP-positive patients showed lower CagA positivity (9% vs. 50.2%, p < 0.0001). There was a higher prevalence of HP infection in patients who underwent lung transplant because of pulmonary fibrosis (p = 0.049), and a lower prevalence in COPD patients (p = 0.011). No correlation was found between HP infection in lung transplant patients and graft outcome. No differences in primary graft dysfunction, acute rejection or bronchiolitis obliterans syndrome-free survival were found. However, more patients who required three or more post-transplant re-hospitalisations were observed among HP-positive patients.

Conclusions

The prevalence of HP infection in lung transplant patients was comparable to that of the general population and to that reported in heart and kidney transplant recipients. It did not seem to impact short-, mid- or long-term lung allograft outcome. H. pylori infection did not prove to be clinically relevant in lung transplant patients.

Keywords

Helicobacter pylori Lung transplantation Epidemiology 

Notes

Acknowledgements

The authors are grateful to Dr. Laura Bergantini, MSC for her help in lab analysis and sample preparation.

Author contributions

DB: study concept and design; acquisition of data; analysis and interpretation of data; drafting of the manuscript; critical revision of the manuscript for important intellectual content; statistical analysis; study supervision. AF: acquisition of data; analysis and interpretation of data; statistical analysis; critical revision of the manuscript for important intellectual content. GC: acquisition of data. RMR: acquisition of data; analysis and interpretation of data. LL: acquisition of data; technical or material support. PP: acquisition of data; technical or material support. MM: acquisition of data; technical or material support. NF: study concept and design; analysis and interpretation of data; critical revision of the manuscript for important intellectual content. RN: critical revision of the manuscript for important intellectual content. PR: critical revision of the manuscript for important intellectual content and study supervision.

Compliance with Ethical Standards

Conflict of interest

None of the authors have any competing interests to declare.

References

  1. 1.
    Siddique O, Ovalle A, Siddique AS, Moss SF (2018) Helicobacter pylori infection: an update for the internist in the age of increasing global antibiotic resistance. Am J Med 131(5):473–479CrossRefGoogle Scholar
  2. 2.
    Tonkic A, Tonkic M, Lehours P, Mégraud F (2012) Epidemiology and diagnosis of Helicobacter pylori infection. Helicobacter 17(Suppl 1):1–8CrossRefGoogle Scholar
  3. 3.
    Pellicano R, Ribaldone D, Fagonee S, Astegiano M, Saracco G, Mégraud F (2016) A 2016 panorama of Helicobacter pylori infection: key messages for clinicians. Panminerva Med 58:304–317.Google Scholar
  4. 4.
    Lee YC, Chiang TH, Chou CK, Tu YK, Liao WC, Wu MS, Graham DY (2016) Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology 150(5):1113–1124.e5CrossRefGoogle Scholar
  5. 5.
    Venerito M, Vasapolli R, Rokkas T, Delchier JC, Malfertheiner P (2017) Helicobacter pylori, gastric cancer and other gastrointestinal malignancies. Helicobacter.  https://doi.org/10.1111/hel.12413 Google Scholar
  6. 6.
    Lai CY, Yang TY, Lin CL, Kao CH (2015) Helicobacter pylori infection and the risk of acute coronary syndrome: a nationwide retrospective cohort study. Eur J Clin Microbiol Infect Dis 34(1):69–74CrossRefGoogle Scholar
  7. 7.
    Niccoli G, Roberto M, D’Amario D, Scalone G, Fracassi F, Cosentino N, Candelli M, Franceschi F, Crea F (2017) Cytotoxin-associated gene antigen-positive strains of Helicobacter pylori and recurring acute coronary syndromes. Eur Heart J Acute Cardiovasc Care 6(6):535–544CrossRefGoogle Scholar
  8. 8.
    Wright CB, Gardener H, Dong C, Yoshita M, DeCarli C, Sacco RL, Stern Y, Elkind MS (2015) Infectious burden and cognitive decline in the Northern Manhattan Study. J Am Geriatr Soc 63(8):1540–1545CrossRefGoogle Scholar
  9. 9.
    Guarneri C, Lotti J, Fioranelli M, Roccia MG, Lotti T, Guarneri F (2017) Possible role of Helicobacter pylori in diseases of dermatological interest. J Biol Regul Homeost Agents 31(Suppl 2):57–77Google Scholar
  10. 10.
    Hudak L, Jaraisy A, Haj S, Muhsen K (2017) An updated systematic review and meta-analysis on the association between Helicobacter pylori infection and iron deficiency anemia. Helicobacter 22(1):e12330CrossRefGoogle Scholar
  11. 11.
    Kuwana M (2014) Helicobacter pylori-associated immune thrombocytopenia: clinical features and pathogenic mechanisms. World J Gastroenterol 20(3):714–723CrossRefGoogle Scholar
  12. 12.
    Rocha AM, Souza C, Melo FF, Clementino NC, Marino MC, Rocha GA, Queiroz DM (2015) Cytokine profile of patients with chronic immune thrombocytopenia affects platelet count recovery after Helicobacter pylori eradication. Br J Haematol 168(3):421–428CrossRefGoogle Scholar
  13. 13.
    Bennett D, Bargagli E, Refini RM, Campagna MS, Gennari L, Nuti R, Figura N, Rottoli P (2014) Helicobacter pylori seroprevalence in patients with idiopathic pulmonary fibrosis. Eur Respir J 43(2):635–638CrossRefGoogle Scholar
  14. 14.
    Samareh Fekri M, Hashemi Bajgani SM, Rasti A, Yazdani R, Mollaie HR (2014) Detection of helicobacter pylori in bronchoalveolar lavage of patients with chronic obstructive pulmonary disease by real time polymerase chain reaction. Jundishapur J Microbiol 8(1):e14551CrossRefGoogle Scholar
  15. 15.
    Sze MA, Chen YW, Tam S, Tashkin D, Wise RA, Connett JE, Man SP, Sin DD (2015) The relationship between Helicobacter pylori seropositivity and COPD. Thorax 70(10):923–929CrossRefGoogle Scholar
  16. 16.
    Chen C, Xun P, Tsinovoi C, He K (2017) Accumulated evidence on Helicobacter pylori infection and the risk of asthma: A meta-analysis. Ann Allergy Asthma Immunol 119(2):137–145.e2CrossRefGoogle Scholar
  17. 17.
    Nakashima S, Kakugawa T, Yura H, Tomonaga M, Harada T, Hara A, Hara S, Nakano M, Yamasaki E, Sakamoto N, Ishimatsu Y, Isomoto H, Gochuico BR, Suffredini AF, Mukae H, Kurazono H, Hirayama T, Moss J, Kohno S (2015) Identification of Helicobacter pylori VacA in human lung and its effects on lung cells. Biochem Biophys Res Commun 460(3):721–726CrossRefGoogle Scholar
  18. 18.
    Huwez FU, Belcher PR, McPhaden AR, Naik SK, Wheatley DJ (1997) Histologically diagnosed Helicobacter pylori in heart transplant recipients. J Heart Lung Transplant 16(6):596–599Google Scholar
  19. 19.
    Hussein NR, Saleem ZS, Balatay AA, Abd KH, Daniel S, Taha AA, Ibrahim NM, Assafi MS (2016) Seroprevalence of Helicobacter pylori infection in renal transplant recipient attending Duhok Kidney Disease Center. Transplant Proc 48(1):92–95CrossRefGoogle Scholar
  20. 20.
    Sarkio S, Rautelin H, Kyllönen L, Honkanen E, Salmela K, Halme L (2001) Should Helicobacter pylori infection be treated before kidney transplantation? Nephrol Dial Transplant 16(10):2053–2057CrossRefGoogle Scholar
  21. 21.
    Hosotani Y, Kawanami C, Hasegawa K, Watanabe T, Ito T, Oike F, Kaihara S, Okazaki K, Tanaka K, Chiba T (2003) A role of Helicobacter pylori infection in the development of duodenal ulcer after adult living-related liver transplantation. Transplantation 76(4):702–704CrossRefGoogle Scholar
  22. 22.
    Kreuter M, Kirsten D, Bahmer T, Penzel R, Claussen M, Ehlers-Tenenbaum S, Muley T, Palmowski K, Eichinger M, Leider M, Herth FJ, Rabe KF, Bittmann I, Warth A (2016) Screening for Helicobacter pylori in idiopathic pulmonary fibrosis lung biopsies. Respiration 91(1):3–8CrossRefGoogle Scholar
  23. 23.
    Khamri W, Walker MM, Clark P, Atherton JC, Thursz MR, Bamford KB, Lechler RI, Lombardi G (2010) Helicobacter pylori stimulates dendritic cells to induce interleukin-17 expression from CD4 + T lymphocytes. Infect Immun 78(2):845–853CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • David Bennett
    • 1
    Email author
  • Antonella Fossi
    • 1
  • Giuseppina Chiarello
    • 1
  • Rosa Metella Refini
    • 1
  • Luca Luzzi
    • 2
  • Piero Paladini
    • 2
  • Maria Materozzi
    • 3
  • Natale Figura
    • 3
  • Ranuccio Nuti
    • 3
  • Paola Rottoli
    • 1
  1. 1.Respiratory Diseases and Lung Transplantation, Department of Medical and Surgical Sciences & NeurosciencesUniversity of SienaSienaItaly
  2. 2.Thoracic Surgery, Department of Medical and Surgical Sciences & NeurosciencesUniversity of SienaSienaItaly
  3. 3.Internal Medicine, Department of Medical and Surgical Sciences & NeurosciencesUniversity of SienaSienaItaly

Personalised recommendations